Prothrombin complex concentrates rapidly reverse coagulopathy, and this treatment is preferred over fresh frozen plasma, especially in patients with cardiac and renal failure who poorly tolerate fluid overload [139]. If anticoagulant therapy has been prescribed there is a high-probability that this patients are at high risk of thrombosis; treatment with low-molecular-weight or unfractionated Selleck BVD-523 heparin should be considered in almost all cases [94]. However the treatment with unfractionated heparin in the initial stage can be more easily controlled than low molecolar weight heparin. Bleeding in patients treated with new oral anticoagulants (NOACs), which include dabigatran,
rivaroxaban, apixaban, and edoxaban, represents an extreme challenge. Currently no antidote exists to reverse the effects of these drugs. Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as monoclonal antibodies against 3-deazaneplanocin A solubility dmso www.selleckchem.com/products/BafilomycinA1.html the direct thrombin inhibitor dabigatran or recombinant Xa-analog in the case of factor Xa inhibitors, are still being investigated in early clinical trials. In certain situations, as in case of emergency surgery or life-threatening major bleeding, a rapid reversal strategy
is needed. Several non-specific prohemostatic agents or coagulation factor concentrates have been suggested as potential candidates for the reversal of NOACs. Activated prothrombin complex concentrate seems promising for the reversal of dabigatran, while non-activated prothrombin complex concentrates have potential for the reversal of anti-factor Xa [140]. In such cases a consultation between critical care speciliast, haematologist and a nephrologists is recommended.
This article contains supplemental online multimedia material. Electronic supplementary Phosphoprotein phosphatase material Additional file 1: Video 1: Laparoscopic suture and repair of perforated and bleeding ulcer in a patient hemodynamically stable; Operating Surgeon Dr. Salomone Di Saverio MD. (WMV 17 MB) Additional file 2: Video 2: Difficult localization of a small PPU: use of Methylene Blue via NGT for localization; Operating Surgeon Dr. Salomone Di Saverio MD. (WMV 11 MB) Additional file 3: Video 3: Technique of laparoscopic primary suture and repair of PPU larger than 1 cm; Operating Surgeon Dr. Salomone Di Saverio MD. (AVI 19 MB) Additional file 4: Video 4: Laparoscopic finding of a very large malignant perforated ulcer of the posterior gastric wall: an indication for conversion and open total gastrectomy; Operating Surgeon Dr. Salomone Di Saverio MD. (AVI 20 MB) References 1. Zelickson MS, Bronder CM, Johnson BL, Camunas JA, Smith DE, Rawlinson D, Von S, Stone HH, Taylor SM: Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg 2011, 77:1054–1060. PMID: 21944523PubMed 2. Bertleff MJ, Lange JF: Perforated peptic ulcer disease: areview of history and treatment.